Humacyte Inc
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | |
| – | +24.9% | -2.3% | -0.4% | -6.0% | -6.9% | -25.9% | |
| – | +5.3% | +116.1% | -39.0% | +10.4% | -10.1% | +58.9% | |
| – | +8.4% | -1,084.4% | – | – | – | – | |
| – | -623.0% | – | – | +538.6% | -95.3% | -7,622.5% | |
| – | -96.1% | -30.8% | +376.4% | +117.6% | -31.1% | -43.8% | |
| – | -96.7% | +2,967.2% | – | -103.6% | +808.7% | -43.8% | |
| – | – | – | – | – | – | – | |
| – | – | – | -99.8% | – | – | – | |
| – | – | +1,593.8% | -106.7% | +1,619.6% | -92.4% | – | |
| – | – | +12,910.9% | -100.5% | – | +2,433.5% | -46.2% | |
| – | – | +344.7% | -138.1% | – | – | -406.7% | |
| – | – | – | – | – | – | – |
Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.